Clinical Trials Browser

Phase 1 × Interventional × Mammary Neoplasms, Animal × Clear all

NCT06251544 2026-03-04

TRAIL-R2 and HER2 Bi-Specific Chimeric Antigen Receptor (CAR) T Cells for the Treatment of Metastatic Breast Cancer

Phase 1 Not yet recruiting

Breast Neoplasms, Mammary Neoplasms, Animal